Information Drought is Over but what does it all m
Post# of 7807
(Total Views: 357)
Posted On: 02/26/2022 2:12:03 PM
Information Drought is Over but what does it all mean?
* $200k in New International Orders (1 existing customer and 2 new ones, BIEL is growing their customer base)
* $3.6 Billion, 13,000 Employee Stada is now an ActiPatch Distributor in the Middle East (this is the Partner I have been waiting for, Stada is a massive company handling Medical Products Distribution in 120 Countries, look for expansion of ActiPatch Distribution in many of their 120 Countries)
* Ms. Anwar-Dean's expansion into Production Scheduling, Inventory Management, Order Fulfillment Management (this indicates an increase in demand for BIEL Products, a sharp BIEL veteran will be in charge of making sure customers get devices on time)
* Ms. Zoya Atiq's hiring as Medical Device Compliance Engineer, Technical Writing, Clinical Trial Writing (you don't hire a fulltime employee for Technical/Clinical Writing unless you plan on a large, sustained need for this expertise)
* Stanford Medical Center Clinical trial for Thumb Arthritis, 120 Patients (this is what BIEL needs, larger Trials from top shelf medical establishments and expansion of Indications to attract new Partners )
* Dog Arthritis 70 patients, Higher Powered Device being Explored, Results due in a few months (finally after years of teasing actual testing of an Enhanced Actipatch, this is Huge, ActiPatch is limited to 2" of penetration into the body and signal strength diminishes the deeper it goes, a higher powered ActiPatch opens up new uses and quicker results for existing uses)
* Total Knee Replacement, Major Surgical Center known for TKA, 180 patient plus 180 control group (this is a Retrospective Study meaning no waiting to recruit patients or gather the data, results due Summer 2022)
* UC San Diego Researchers in Pilot Stage of Studies on Refractory Phantom Pain & Total Knee/Hip Replacement Pain (major well known university means more attention and weight given to results)
* BIEL is in talks with 2 Research Teams for Studies on Wound Care (BIEL is in overdrive with the Research/Clinical projects, someone has to be funding his besides BIEL)
Thanks to Seven-up for sharing this Update. Should show up as a PR on Monday.
* $200k in New International Orders (1 existing customer and 2 new ones, BIEL is growing their customer base)
* $3.6 Billion, 13,000 Employee Stada is now an ActiPatch Distributor in the Middle East (this is the Partner I have been waiting for, Stada is a massive company handling Medical Products Distribution in 120 Countries, look for expansion of ActiPatch Distribution in many of their 120 Countries)
* Ms. Anwar-Dean's expansion into Production Scheduling, Inventory Management, Order Fulfillment Management (this indicates an increase in demand for BIEL Products, a sharp BIEL veteran will be in charge of making sure customers get devices on time)
* Ms. Zoya Atiq's hiring as Medical Device Compliance Engineer, Technical Writing, Clinical Trial Writing (you don't hire a fulltime employee for Technical/Clinical Writing unless you plan on a large, sustained need for this expertise)
* Stanford Medical Center Clinical trial for Thumb Arthritis, 120 Patients (this is what BIEL needs, larger Trials from top shelf medical establishments and expansion of Indications to attract new Partners )
* Dog Arthritis 70 patients, Higher Powered Device being Explored, Results due in a few months (finally after years of teasing actual testing of an Enhanced Actipatch, this is Huge, ActiPatch is limited to 2" of penetration into the body and signal strength diminishes the deeper it goes, a higher powered ActiPatch opens up new uses and quicker results for existing uses)
* Total Knee Replacement, Major Surgical Center known for TKA, 180 patient plus 180 control group (this is a Retrospective Study meaning no waiting to recruit patients or gather the data, results due Summer 2022)
* UC San Diego Researchers in Pilot Stage of Studies on Refractory Phantom Pain & Total Knee/Hip Replacement Pain (major well known university means more attention and weight given to results)
* BIEL is in talks with 2 Research Teams for Studies on Wound Care (BIEL is in overdrive with the Research/Clinical projects, someone has to be funding his besides BIEL)
Thanks to Seven-up for sharing this Update. Should show up as a PR on Monday.
(4)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼